Epilepsy research charity warns against unlicensed CBD products

A British health charity has warned people with epilepsy against using CBD products that do not have a pharmaceutical licence.

Epilepsy Research UK, a national organisation which funds research, says that “whilst there is evidence that medical-grade preparations of an active ingredient of cannabis, cannabidiol, can be beneficial in some types of epilepsy, cannabis oil itself cannot be considered a safe or effective treatment. This is due to the variety of compounds found in over-the-counter cannabis oils, some of which may have harmful effects.”

...

Need help?

Contact a sales representative right now and don’t wait

Erik Galavis
+34 654 320 547
Email Erik

Restricted content. Do you want to read more?

Request report

Interested in buying?
Request more information

MORE INFO

Visit store

Check out our reports
available for purchase

VIEW REPORTS

Request a free sample of this report:

“ Epilepsy research charity warns against unlicensed CBD products ”

    This file is not available, please fill the form to request your sample page:






    Buy report request information:

    “ Epilepsy research charity warns against unlicensed CBD products ”






      A British health charity has warned people with epilepsy against using CBD products that do not have a pharmaceutical licence.

      Epilepsy Research UK, a national organisation which funds research, says that “whilst there is evidence that medical-grade preparations of an active ingredient of cannabis, cannabidiol, can be beneficial in some types of epilepsy, cannabis oil itself cannot be considered a safe or effective treatment. This is due to the variety of compounds found in over-the-counter cannabis oils, some of which may have harmful effects.”

      ...

      Benefits of subscription plans:

      • Stay informed of any legal and market change in the sector that impacts your organization
      • Maximise resources by getting market and legal data analysis daily in one place
      • Make smart decisions by understanding how the regulatory and market landscape evolves
      • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

      Need help?

      Contact a sales representative right now and don’t wait

      Erik Galavis
      +34 654 320 547
      Email Erik